Stockscreener 앱 받기
137.99
3.35%
-4.78
시간 외 거래:
136.53
-1.46
-1.06%
전일 마감가:
$142.77
열려 있는:
$137.19
하루 거래량:
26.18M
Relative Volume:
2.18
시가총액:
$55.09B
수익:
$2.23B
순이익/손실:
$-3.19B
주가수익비율:
-16.94
EPS:
-8.1462
순현금흐름:
$-1.60B
1주 성능:
-4.92%
1개월 성능:
+147.27%
6개월 성능:
+157.59%
1년 성능:
+463.91%
1일 변동 폭
$133.33
$138.80
1주일 범위
$130.00
$161.37
52주 변동 폭
$22.28
$176.66
모더나 Stock (MRNA) Company Profile
명칭
Moderna Inc
전화
(617) 714-6500
주소
325 BINNEY STREET, CAMBRIDGE
Compare MRNA vs VRTX, REGN, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
137.99 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
VRTX
Vertex Pharmaceuticals Inc
|
541.69 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
794.19 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,023.21 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
207.88 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
모더나 Stock (MRNA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-28 | 재개 | Barclays | Equal Weight |
| 2026-01-07 | 재개 | UBS | Neutral |
| 2025-12-12 | 개시 | Jefferies | Hold |
| 2025-03-13 | 개시 | Citigroup | Neutral |
| 2025-02-18 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2025-01-29 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-12-18 | 다운그레이드 | Argus | Buy → Hold |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-19 | 개시 | Berenberg | Hold |
| 2024-11-18 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Underperform |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-09-13 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2024-09-13 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-09-13 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-08-28 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2024-08-07 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-08-05 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | 다운그레이드 | HSBC Securities | Hold → Reduce |
| 2024-01-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-11-29 | 개시 | Canaccord Genuity | Hold |
| 2023-11-03 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2023-11-02 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2023-08-04 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-07-24 | 개시 | William Blair | Mkt Perform |
| 2023-07-14 | 개시 | HSBC Securities | Reduce |
| 2023-06-26 | 업그레이드 | UBS | Neutral → Buy |
| 2023-04-26 | 개시 | Guggenheim | Neutral |
| 2023-03-13 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | 개시 | RBC Capital Mkts | Outperform |
| 2023-02-24 | 다운그레이드 | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-12-14 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | 업그레이드 | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-02-01 | 업그레이드 | Redburn | Sell → Neutral |
| 2022-01-26 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2022-01-21 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-21 | 개시 | UBS | Neutral |
| 2021-12-07 | 개시 | Cowen | Market Perform |
| 2021-11-09 | 개시 | Wolfe Research | Outperform |
| 2021-10-22 | 개시 | Deutsche Bank | Sell |
| 2021-10-15 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-08-06 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | 재확인 | Jefferies | Hold |
| 2021-02-01 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-12-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-12-16 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-23 | 개시 | Wells Fargo | Equal Weight |
| 2020-11-17 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | 다운그레이드 | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | 개시 | SVB Leerink | Mkt Perform |
| 2020-07-20 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-07-13 | 개시 | Jefferies | Buy |
| 2020-06-30 | 개시 | Argus | Buy |
| 2020-06-08 | 개시 | Barclays | Overweight |
| 2020-04-30 | 개시 | BMO Capital Markets | Outperform |
| 2020-03-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | 재개 | BofA/Merrill | Buy |
| 2019-10-25 | 개시 | ROTH Capital | Buy |
| 2019-04-05 | 개시 | Chardan Capital Markets | Buy |
모두보기
모더나 주식(MRNA)의 최신 뉴스
Moderna cancer vaccine breakthrough revives hopes for biotech turnaround By Investing.com - Investing.com Nigeria
SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology - Stocktwits
Health Care Up as Moderna Leads Biotech HigherHealth Care Roundup - marketscreener.com
Moderna Shares (NASDAQ:MRNA) Finish Landmark Week, Surging 70% Over Wall Street Consensus - TechStock²
SLS Stock Clocks Three Straight Weeks Of Gains On Cancer Vaccine Spillover, REGAL Trial Data Anticipation - Yahoo Finance
Moderna Soars 129% for the Week | Closing Bell - marketscreener.com
Moderna Stock Erupts As Cancer Vaccine Trial Delivers Historic Win - StocksToTrade
Moderna Stock Explodes As Phase 3 Cancer Vaccine Data Hits - timothysykes.com
Moderna, Robinhood, Marvell, Tesla, SpaceX, and More Stocks That Explain Today’s Market - Barron's
Bessent's Bond Rescue, Bitcoin's Best Week Since 2023Coinbase Global (NASDAQ:COIN) - Benzinga
Moderna (MRNA) Cancer Vaccine Success Won’t Lift All mRNA Stocks - Barron's
Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet. - Barchart.com
Moderna’s Cancer Vaccine Breakthrough Sends Stocks Soaring - cheddar.com
Why Moderna’s mRNA Cancer Drug Hype Has Gone Too Far - Barron's
If You Invested $1,000 In Moderna Stock at IPO, Here's How Much You'd Have Now - TradingView
Moderna Stock Explodes As Landmark Cancer Trial Sparks Re‑Rating - StocksToTrade
Moderna Stock Explodes After Landmark Cancer Vaccine Breakthrough - timothysykes.com
How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink - WSJ
Moderna (NASDAQ:MRNA) Price Target Raised to $77.00 at JPMorgan Chase & Co. - MarketBeat
After Moderna’s Big News, Here Are Three Biotechs to Watch - TheStreet Pro
Moderna Inc Stock (MRNA) Moved Up by 14.01% on Aug 21: What Signal Does It Send? - TradingKey
Moderna, Robinhood, Marvell, Tesla, SpaceX, and More Stocks That Explain Today's Market -- Barrons.com - Moomoo
Moderna jumps 18% on investor optimism - Breakingthenews.net
Moderna Options Flash Extreme Caution as Cancer Vaccine Fuels Stock Surge: Options Chatter - Moomoo
Moderna Cancer Vaccine Could Redefine the CompanyModerna (NASDAQ:MRNA) - Benzinga
Moderna (NASDAQ:MRNA) Sees Strong Trading Volume on Analyst Upgrade - MarketBeat
Merck & Co Inc Stock (MRK) Moved Up by 3.41% on Aug 21: Facts Behind the Movement - TradingKey
Moderna Rallies 8%, BioNTech Climbs 4% as the mRNA Trade Whipsaws for a Third Session - Yahoo Finance
Moderna and Merck’s cancer vaccine clears phase 3; Ultragenyx lands gene therapy nod - Pharma Voice
Moderna, Merck mRNA cancer vaccine prevents melanoma from returning in trial - KXAN Austin
Rx Rundown: Moderna, Merck, LEO Pharma and more - Medical Marketing and Media
Moderna’s 177% Surge Has Investors Asking What Comes Next - MarketBeat
Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhyped - MarketWatch
Moderna and Merck cancer vaccine success paves way for future - EMJ
Pharma Bro Admits 'Playing Around' With MRNA Short At $80 Before it Exploded 177% Following Cancer Vax Trials— ‘I Bet You a Bunch of People Got Fired’ - Yahoo Finance
Meeder Advisory Services Inc. Buys New Shares in Moderna, Inc. $MRNA - MarketBeat
MEXC Lists Ondo Tokenized Stock Moderna (MRNAON), Expanding Access to U.S. Biotech Exposure - TradingView
A Cancer Vaccine Is Closer Than Ever - Bloomberg.com
Amid the chip bear market, healthcare is breaking out: Chart of the Day - Yahoo Finance
JPMorgan Adjusts Price Target on Moderna to $77 From $40, Keeps Underweight Rating - marketscreener.com
Elon Musk Says mRNA Has ‘Tremendous’ Potential After Moderna, Merck Cancer Vaccine Breakthrough — MRNA Stock Falls Over 11% in Premarket (UPDATED) - Yahoo Finance
Personalized cancer vaccine launched by Moderna: Drug firm’s shares soar more than 100% — should you buy? - Yahoo! Finance Canada
Mitsubishi UFJ Asset Management Co. Ltd. Acquires New Holdings in Moderna, Inc. $MRNA - MarketBeat
983,450 Shares in Moderna, Inc. $MRNA Bought by Deutsche Bank AG - MarketBeat
Moderna (MRNA) Clears A Phase 3 Milestone, Is The Upside Already Priced In? - Yahoo Finance
5 Reasons Why Moderna Stock Jumped 170% and How Far It Can Go - CryptoRank
Watch Moderna, Merck Cancer Vax Gives Hope - Bloomberg.com
Moderna, Merck develop vaccine that could help fight against melanoma - cbs8.com
Moderna (MRNA) Sees Stock Surge After Positive Melanoma Trial Re - GuruFocus
FDA approves Moderna's mRNA seasonal flu vaccineABC News - ABC News - Breaking News, Latest News and Videos
Moderna's Comeback Is Finally Taking Shape -- and There May Be More Upside Ahead - Yahoo Finance
모더나 (MRNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
모더나 주식 (MRNA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bancel Stephane | Chief Executive Officer |
Aug 06 '26 |
Option Exercise |
19.15 |
252,469 |
4,834,781 |
6,440,260 |
| Bancel Stephane | Chief Executive Officer |
Aug 05 '26 |
Sale |
57.52 |
499,246 |
28,715,011 |
6,187,791 |
3.37%
0.23%
자본화:
|
볼륨(24시간):